News tagged with cancer drugs

US OKs first-ever DNA alternative to Pap smear (Update 2)

U.S. government health regulators have cleared a genetic test from Roche as a first-choice screening option for cervical cancer. It was a role previously reserved for the Pap smear, the decades-old mainstay of women's health.

Apr 24, 2014
popularity 5 / 5 (1) | comments 0

Cyramza approved for stomach cancer

(HealthDay)—Cyramza (ramucirumab) has been approved by the U.S. Food and Drug Administration to treat cancer of the stomach or of the area where the esophagus joins the stomach (the gastroesophageal junction).

Apr 22, 2014
popularity not rated yet | comments 0

'Dustman' protein helps bin cancer cells

Cancer researchers have discovered a new 'dustman' role for a molecule that helps a drug kill cancer cells according to a study, published in the journal Proceedings of the National Academy of Sciences (PNAS) ...

Apr 21, 2014
popularity 4.8 / 5 (4) | comments 0

Solving cancer's secrets

Some fathers play ball with their sons. Or take them fishing. Chuck Perou's father took his son to his pathology lab to show him how a pathologist conducts tests and runs experiments. Perou, a nature junky ...

Apr 21, 2014
popularity 4.7 / 5 (3) | comments 0

Cancer stem cells linked to drug resistance

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered ...

Apr 20, 2014
popularity 5 / 5 (1) | comments 0

Drug watchdog urges vigilance in cancer drug theft

Europe's medicine watchdog urged doctors Thursday to be vigilant in administering the cancer drug Herceptin, vials of which had been stolen in Italy and tampered with before being sold back into the supply chain.

Apr 17, 2014
popularity not rated yet | comments 0

Developing new anti-cancer medicines

The prospect of four new cancer medicines becoming a reality for patients has taken a huge step forward with the announcement of a £34M investment by a European private biotech company in University research.

Apr 11, 2014
popularity 5 / 5 (2) | comments 0